Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Endocrine 1

Conditions

Prostatic Neoplasms 1Pain, Postoperative 1Multiple Endocrine Neoplasia Type 1 1

Interventions

Bupivacaine 18Ropivacaine 10Saline Solution 9Dexmedetomidine 9Sodium Chloride 5Pregabalin 5Morphine 5Ketamine 5Lidocaine 4Dexamethasone 4Control Groups 4Analgesia, Patient-Controlled 4Tea 3Gabapentin 3Anesthetics, Local 3Acetaminophen 3Population Groups 2Parapsychology 2Magnesium Sulfate 2Injections, Epidural 2Fentanyl 2Dental Occlusion 2Anti-Inflammatory Agents, Non-Steroidal 2Analgesics, Opioid 2thiamine triphosphorate 1ramosetron 1parecoxib 1gamma-Aminobutyric Acid 1esmolol 1Water 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pain, Postoperative × Acetazolamide × Clear all
NCT04470843 2022-09-23

Impact of Acetazolamide in Reducing Referred Postoperative Pain

Medical College of Wisconsin

Phase 1 Completed
33 enrolled
EndocrineGenitourinary

Pain, Postoperative, Prostatic Neoplasms, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡